tirzepatide and prediabetes Is Zepbound (tirzepatide) approved for the treatment of prediabetes? Tirzepatide in Patients with Obesity

If you use the upper arm, make sure you can reach the approved back or outer area without twisting or rushing, or ask whether another person should help

Designed for individuals with a BMI of 30 or higher, or 27 with weight-related conditions, Wegovy has shown remarkable results

Support materials, dosing protocols, and access to provider guidance ensure that non-diabetic patients new to GIP-GLP-1 receptor agonists feel confident managing their treatment independently

2025;37(5):1060-1074.e4

Taken together, the available literature provides coherent guidance, interpreting the available data as signaling a possible, but still low certainty, increase in NAION risk with semaglutide, while framing this against the drugs substantial cardiometabolic benefits

These medications act on appetite and reward pathways in the brain as well as digestive and metabolic pathways in the body